医学
炎症性肠病
疾病
重症监护医学
临床试验
人口
克罗恩病
免疫学
生物信息学
内科学
生物
环境卫生
作者
Andreas Stallmach,Raja Atreya,Philip Grunert,Johannes Stallhofer,Jan de Laffolie,Carsten Schmidt
标识
DOI:10.3238/arztebl.m2023.0142
摘要
The treatment of a patient with IBD must take his or her prior treatment(s) and comorbidities into account, along with individual patient characteristics and treatment goals. Rational decision-making is required on the basis of the mechanism of action and the side-effect profile of the various drugs that are now available for use.
科研通智能强力驱动
Strongly Powered by AbleSci AI